The Regional 
Regional Climate Action
Transparency Hub For Central Asia
Antibiotics are essential for combating dangerous infections and saving millions of lives each year. However, following use, a portion of these pharmaceuticals enters the environment, where they can persist, affect living organisms, and facilitate the proliferation of treatment-resistant bacteria.
A previously released but highly detailed interview on the ALKANOV channel takes an in-depth look at the project called "One Village — One Product."
Central Asia is a “blind spot” in global antimicrobial resistance (AMR) surveillance: data are scarce, while antibiotic consumption in the region remains high. In 2019, bacterial AMR was associated with 4.95 million deaths worldwide, 1.27 million of which were directly attributable to it [1]; by 2050, 1.91 million attributable and 8.22 million associated deaths per year are projected [3].
Representatives of government agencies of the Kyrgyz Republic, international organizations and One Health programme partners discussed strengthening preparedness for pandemics and emergencies. Key priorities included the early detection of infectious disease threats, the development of laboratory infrastructure, interagency coordination and the development of a national action plan.
Upcoming events
Next events
